Table 1.
Patients’ characteristics.
| Characteristic | N | % |
|---|---|---|
| All pts | 159 | |
| Median age, years (range) | 54 (29–81) | |
| Surgery type | ||
| Lumpectomy | 108 | 68 |
| Mastectomy | 51 | 32 |
| Histology | ||
| IDC | 146 | 92 |
| ILC | 5 | 3 |
| Other | 8 | 5 |
| pT | ||
| 1 | 82 | 52 |
| 2 | 60 | 38 |
| 3 | 16 | 10 |
| 4 | 1 | 1 |
| pN | ||
| 0 | 80 | 50 |
| 1 | 49 | 31 |
| 2 | 14 | 9 |
| 3 | 12 | 8 |
| x | 4 | 3 |
| NLR | ||
| 0.5–1 | 9 | 6 |
| 1–1.5 | 19 | 12 |
| 1.5–2 | 26 | 16 |
| 2–2.5 | 37 | 23 |
| > 2.5 | 68 | 43 |
| TILs | ||
| 0 | 24 | 15 |
| 1–10 | 59 | 37 |
| > 10 | 68 | 43 |
| LPBC | 5 | 3 |
| NE | 8 | 5 |
| AR | ||
| POS | 77 | 48 |
| NEG | 74 | 47 |
| NE | 8 | 5 |
| BMI | ||
| ≤ 25 | 76 | 48 |
| 25–29 | 27 | 17 |
| ≥ 30 | 19 | 12 |
| NE | 37 | 23 |
| Adjuvant CT | ||
| Anthracycline-based | 20 | 13 |
| Taxane-based | 7 | 4 |
| Anthracycline/Taxane-based | 87 | 55 |
| CMF | 18 | 11 |
| None | 21 | 13 |
| UK | 6 | 4 |
| Adjuvant RT | ||
| Yes | 112 | 70 |
| No | 41 | 26 |
| UK | 6 | 4 |
| Recurrence | ||
| Ipsilateral | 2 | 1 |
| Contralateral | 4 | 3 |
| Metastatic | 38 | 24 |
| None | 115 | 72 |
IDC invasive ductal carcinoma, ILC invasive lobular carcinoma, NLR neutrophils to lymphocytes ratio, TILs tumor infiltrating lymphocytes, LPBC lymphocyte predominant breast cancer, NE not evaluable, AR androgen receptor, POS positive, NEG negative, BMI Body Mass Index, CT chemotherapy, CMF cyclophosphamide-methotrexate-fluorouracil, UK unknown, RT radiotherapy.